Neurochem Submits First Unit Of Fibrillex Rolling NDA
The amyloid A amyloidosis agent is part of the Pilot 1 and Pilot 2 programs overseen by FDA's Division of Cardio-Renal Drug Products.
The amyloid A amyloidosis agent is part of the Pilot 1 and Pilot 2 programs overseen by FDA's Division of Cardio-Renal Drug Products.